BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 25130488)

  • 41. Evaluation of fluorescence in-situ hybridization in monomorphic endometrial stromal neoplasms and their histological mimics: a review of 49 cases.
    Stewart CJ; Leung YC; Murch A; Peverall J
    Histopathology; 2014 Oct; 65(4):473-82. PubMed ID: 24592973
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pleomorphic high grade endometrial stromal sarcoma with
    Ullah A; Arbindi H; Zola F; Mattox SN; Velasquez Zarate L; Munroe J; Heneidi S; Sharma S; Ghamande S; Kleven DT
    Int J Clin Exp Pathol; 2022; 15(2):72-78. PubMed ID: 35265255
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Breakages at YWHAE, FAM22A, and FAM22B loci in uterine angiosarcoma: a case report with immunohistochemical and genetic analysis.
    Suzuki S; Tanioka F; Minato H; Ayhan A; Kasami M; Sugimura H
    Pathol Res Pract; 2014 Feb; 210(2):130-4. PubMed ID: 24125656
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Uterine epithelioid leiomyosarcoma with c-kit expression and YWHAE gene rearrangement: a case report of a diagnostic pitfall of uterine sarcoma.
    Kubo T; Sugita S; Wada R; Kikuchi N; Iwasaki M; Ito Y; Sugawara T; Fujita H; Emori M; Tanaka R; Hirano H; Saito T; Hasegawa T
    Diagn Pathol; 2017 Mar; 12(1):26. PubMed ID: 28288693
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histopathologic prognostic factors in stage I leiomyosarcoma of the uterus: a detailed analysis of 27 cases.
    Wang WL; Soslow R; Hensley M; Asad H; Zannoni GF; de Nictolis M; Branton P; Muzikansky A; Oliva E
    Am J Surg Pathol; 2011 Apr; 35(4):522-9. PubMed ID: 21383611
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
    Suthipintawong C; Wejaranayang C; Vipupinyo C
    J Med Assoc Thai; 2008 Dec; 91(12):1779-84. PubMed ID: 19133508
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-Grade Endometrial Stromal Sarcomas With YWHAE::NUTM2 Gene Fusion Exhibit Recurrent CDKN2A Alterations and Absence of p16 Staining is a Poor Prognostic Marker.
    Kommoss FKF; Mar LM; Howitt BE; Hanley K; Turashvilli G; Buslei R; Irving JA; Dickson BC; Koelsche C; Sinn HP; Schirmacher P; von Deimling A; Chiang S; McCluggage WG; Croce S; Stewart CJR; Lee CH
    Mod Pathol; 2023 Mar; 36(3):100044. PubMed ID: 36788095
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular Cytogenetic Analysis of JAZF1, PHF1, and YWHAE in Endometrial Stromal Tumors: Discovery of Genetic Complexity by Fluorescence in Situ Hybridization.
    Hodge JC; Bedroske PP; Pearce KE; Sukov WR
    J Mol Diagn; 2016 Jul; 18(4):516-26. PubMed ID: 27154512
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunohistochemical analysis of p53 protein in uterine sarcomas.
    Nordal RR; Kristensen GB; Stenwig AE; Tropé CG; Nesland JM
    Gynecol Oncol; 1998 Jul; 70(1):45-8. PubMed ID: 9698472
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Extended resection including adjacent organs and Ki-67 labeling index are prognostic factors in patients with retroperitoneal soft tissue sarcomas.
    Morizawa Y; Miyake M; Shimada K; Hori S; Tatsumi Y; Nakai Y; Anai S; Tanaka N; Konishi N; Fujimoto K
    World J Surg Oncol; 2016 Feb; 14(1):43. PubMed ID: 26911364
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
    Alvarez T; Miller E; Duska L; Oliva E
    Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recent Developments in Surgical Pathology of the Uterine Corpus.
    Hanley KZ; Birdsong GG; Mosunjac MB
    Arch Pathol Lab Med; 2017 Apr; 141(4):528-541. PubMed ID: 28353387
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endometrial stromal sarcoma: clinicopathological and immunophenotypic study of 16 cases.
    Iwasaki S; Sudo T; Miwa M; Ukita M; Morimoto A; Tamada M; Ueno S; Wakahashi S; Yamaguchi S; Fujiwara K; Sakuma Y; Mikami Y; Nishimura R
    Arch Gynecol Obstet; 2013 Aug; 288(2):385-91. PubMed ID: 23435725
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic significance of bcl-2, c-myc, survivin and tumor grade in synovial sarcoma.
    Demır D; Yaman B; Anacak Y; Keçecı B; Kandıloğlu G; Akalin T
    Turk Patoloji Derg; 2014; 30(1):55-65. PubMed ID: 24448706
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic value of the diagnostic criteria distinguishing endometrial stromal sarcoma, low grade from undifferentiated endometrial sarcoma, 2 entities within the invasive endometrial stromal neoplasia family.
    Feng W; Malpica A; Robboy SJ; Gudlaugsson E; Hua K; Zhou X; Baak JP
    Int J Gynecol Pathol; 2013 May; 32(3):299-306. PubMed ID: 23545579
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Beta-catenin expression in uterine sarcomas and its relation to clinicopathological parameters.
    Kildal W; Pradhan M; Abeler VM; Kristensen GB; Danielsen HE
    Eur J Cancer; 2009 Sep; 45(13):2412-7. PubMed ID: 19622417
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High coexpression of CCL2 and CX3CL1 is gender-specifically associated with good prognosis in soft tissue sarcoma patients.
    Kehlen A; Greither T; Wach S; Nolte E; Kappler M; Bache M; Holzhausen HJ; Lautenschläger C; Göbel S; Würl P; Immel UD; Agaimy A; Wullich B; Taubert H
    Int J Cancer; 2014 Nov; 135(9):2096-106. PubMed ID: 24676787
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Management of uterine sarcomas and prognostic indicators: real world data from a single-institution.
    Kyriazoglou A; Liontos M; Ziogas DC; Zagouri F; Koutsoukos K; Tsironis G; Tsiara A; Kaparelou M; Zakopoulou R; Thomakos N; Haidopoulos D; Papaspyrou I; Rodolakis A; Bamias A; Dimopoulos MA
    BMC Cancer; 2018 Dec; 18(1):1247. PubMed ID: 30541504
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The expression of Ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas. A clinicopathologic study.
    Akhan SE; Yavuz E; Tecer A; Iyibozkurt CA; Topuz S; Tuzlali S; Bengisu E; Berkman S
    Gynecol Oncol; 2005 Oct; 99(1):36-42. PubMed ID: 15992918
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic factors in anterior skull base meningiomas.
    Ciocan LM; Dănăilă L; Stănculescu DE; Neamţu SD; Mateescu GO; Stanca L
    Rom J Morphol Embryol; 2014; 55(3 Suppl):1063-9. PubMed ID: 25607386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.